Biodistribution of mesenchymal stem/stromal cells in a preclinical setting

Stem Cells International

Volumn , Issue , 2013, Pages

  Sensebé, Luc ^a,b   Fleury Cappellesso, Sandrine ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA;

ADIPOSE DERIVED STEM CELL; BIOENGINEERING; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL LABELING; CELL TRANSPORT; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; GOOD MANUFACTURING PRACTICE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; NONHUMAN; PATIENT SAFETY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL THERAPY; TISSUE REPAIR; TREATMENT INDICATION;

EID: 84886678859     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/678063     Document Type: Review

References (32)

1. Friedenstein A. J., Gorskaja J. F., Kulagina N. N., Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology 1976 4 5 267 274 2-s2.0-0017119380
2. Caplan A. I., The mesengenic process. Clinics in Plastic Surgery 1994 21 3 429 435 2-s2.0-0028340485 (Pubitemid 24208964)
3. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S. M., Mukhachev V., Lavroukov A., Kon E., Marcacci M., Repair of large bone defects with the use of autologous bone marrow stromal cells. New England Journal of Medicine 2001 344 5 385 386 2-s2.0-0035253558 10.1056/NEJM200102013440516 (Pubitemid 32107654)
4. Takashima Y., Era T., Nakao K., Kondo S., Kasuga M., Smith A. G., Nishikawa S.-I., Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007 129 7 1377 1388 2-s2.0-34250854663 10.1016/j.cell.2007.04.028 (Pubitemid 46970707)
5. Crisan M., Yap S., Casteilla L., Chen C.-W., Corselli M., Park T. S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.-N., Traas J., Schugar R., Deasy B. M., Badylak S., Buhring H.-J., Giacobino J.-P., Lazzari L., Huard J., Péault B., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008 3 3 301 313 2-s2.0-50849139576 10.1016/j.stem.2008.07.003
6. Dominici M., le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
7. de Ugarte D. A., Morizono K., Elbarbary A., Alfonso Z., Zuk P. A., Zhu M., Dragoo J. L., Ashjian P., Thomas B., Benhaim P., Chen I., Fraser J., Hedrick M. H., Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003 174 3 101 109 2-s2.0-10744228149 10.1159/000071150 (Pubitemid 36819010)
8. Phinney D. G., Sensebé L., Mesenchymal stromal cells: misconceptions and evolving concepts. Cytotherapy 2013 15 140 145 10.1016/j.jcyt.2012.11.005
9. le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet 2004 363 9419 1439 1441 2-s2.0-2342482526 10.1016/S0140-6736(04)16104-7 (Pubitemid 38586721)
10. Tan J., Wu W., Xu X., Liao L., Zheng F., Messinger S., Sun X., Chen J., Yang S., Cai J., Gao X., Pileggi A., Ricordi C., Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. Journal of the American Medical Association 2012 307 11 1169 1177 2-s2.0-84858634242 10.1001/jama.2012.316
11. Phinney D. G., Prockop D. J., Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007 25 11 2896 2902 2-s2.0-36249021493 10.1634/stemcells.2007-0637 (Pubitemid 350127874)
12. Breitbach M., Bostani T., Roell W., Xia Y., Dewald O., Nygren J. M., Fries J. W. U., Tiemann K., Bohlen H., Hescheler J., Welz A., Bloch W., Jacobsen S. E. W., Fleischmann B. K., Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007 110 4 1362 1369 2-s2.0-34548044258 10.1182/blood-2006-12-063412 (Pubitemid 47281438)
13. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., Jorgensen C., Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003 102 10 3837 3844 2-s2.0-0242410394 10.1182/blood-2003-04-1193 (Pubitemid 37409409)
14. Houghton J., Li H., Fan X., Liu Y., Liu J. H., Rao V. P., Poutahidis T., Taylor C. L., Jackson E. A., Hewes C., Lyle S., Cerny A., Bowen G., Cerny J., Moore N., Kurt-Jones E. A., Erdman S. E., Mutations in bone marrow-derived stromal stem cells unmask latent malignancy. Stem Cells and Development 2010 19 8 1153 1166 2-s2.0-77956331003 10.1089/scd.2009.0439
15. Bouchez G., Sensebé L., Vourc'h P., Garreau L., Bodard S., Rico A., Guilloteau D., Charbord P., Besnard J.-C., Chalon S., Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochemistry International 2008 52 7 1332 1342 2-s2.0-42149183477 10.1016/j.neuint.2008.02.003
16. + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 2004 103 9 3313 3319 2-s2.0-11144356832 10.1182/blood-2003-04-1121 (Pubitemid 38525658)
17. 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nuclear Medicine and Biology 2011 38 7 961 967 2-s2.0-80053614471 10.1016/j.nucmedbio.2011.03.008
18. 18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastrucute and differentiation capacity. Journal of Nuclear Medicine 2013 54 447 454 10.2967/jnumed.112.108316
19. Vilalta M., Dégano I. R., Bagó J., Gould D., Santos M., García-Arranz M., Ayats R., Fuster C., Chernajovsky Y., García-Olmo D., Rubio N., Blanco J., Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells and Development 2008 17 5 993 1004 2-s2.0-58149170640 10.1089/scd.2007. 0201
20. Chang Y.-K., Liu Y.-P., Ho J. H., Hsu S.-C., Lee O. K., Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells. Journal of Orthopaedic Research 2012 30 1499 1506 2-s2.0-84856979581 10.1002/jor.22088
21. Schmidtke-Schrezenmeier G., Urban M., Musyanovych A., Mailänder V., Rojewski M., Fekete N., Menard C., Deak E., Tarte K., Rasche V., Landfester K., Schrezenmeier H., Labeling of mesenchymal stromal cells with iron oxidepoly(l-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties. Cytotherapy 2011 13 8 962 975 2-s2.0-80051872276 10.3109/14653249.2011.571246
22. Toupet K., Maumus M., Peyrafitte J.-A., Bourin P., van Lent P., Ferreira R., Orsetti B., Pirot N., Casteilla L., Jorgensen C., Noel D., Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection. Arthritis & Rheumatism 2013 65 7 1786 1794 10.1002/art.37960
23. Lee R. H., Pulin A. A., Seo M. J., Kota D. J., Ylostalo J., Larson B. L., Semprun-Prieto L., Delafontaine P., Prockop D. J., Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009 5 1 54 63 2-s2.0-67649171661 10.1016/j.stem.2009.05.003
24. Manz M. G., di Santo J. P., Renaissance for mouse models of human hematopoiesis and immunobiology. Nature Immunology 2009 10 10 1039 1042 2-s2.0-70349459317 10.1038/ni1009-1039
25. Mouiseddine M., François S., Semont A., Sache A., Allenet B., Mathieu N., Frick J., Thierry D., Chapel A., Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. British Journal of Radiology 2007 80 1 S49 S55 2-s2.0-34948819100 10.1259/bjr/25927054 (Pubitemid 47517799)
26. Allers C., Sierralta W. D., Neubauer S., Rivera F., Minguell J. J., Conget P. A., Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 2004 78 4 503 508 2-s2.0-4143122292 10.1097/01.TP.0000128334.93343.B3 (Pubitemid 39097094)
27. Chapel A., Bertho J. M., Bensidhoum M., Fouillard L., Young R. G., Frick J., Demarquay C., Cuvelier F., Mathieu E., Trompier F., Dudoignon N., Germain C., Mazurier C., Aigueperse J., Borneman J., Gorin N. C., Gourmelon P., Thierry D., Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. Journal of Gene Medicine 2003 5 12 1028 1038 2-s2.0-1942528355 10.1002/jgm.452 (Pubitemid 40310427)
28. Mitkari B., Kerkelä E., Nystedt J., Korhonen M., Mikkonen V., Huhtala T., Jolkkonen J., Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Experimental Neurology 2013 239 158 162
29. 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model. Nuclear Medicine and Biology 2010 37 3 381 388 2-s2.0-77950296472 10.1016/j.nucmedbio.2009.12.001
30. Ramot Y., Meiron M., Toren A., Steiner M., Nyska A., Safety and biodistribution profile of Placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery. Toxicologic Pathology 2009 37 5 606 616 2-s2.0-70350444497 10.1177/0192623309338383
31. Bouacida A., Rosset P., Trichet V., Guilloton F., Espagnolle N., Cordonier T., Heymann D., Layrolle P., Sensebe L., Deschaseaux F., Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One 2012 7 11 10.1371/journal.pone.0048648 e48648
32. Ringdén O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lönnies H., Marschall H.-U., Dlugosz A., Szakos A., Hassan Z., Omazic B., Aschan J., Barkholt L., Le Blanc K., Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006 81 10 1390 1397 2-s2.0-33744913533 10.1097/01.tp.0000214462.63943.14 (Pubitemid 43847148)